These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 32740991)
1. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin. Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991 [TBL] [Abstract][Full Text] [Related]
2. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process]. Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696 [TBL] [Abstract][Full Text] [Related]
3. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells. Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461 [TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma. Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520 [TBL] [Abstract][Full Text] [Related]
5. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells. Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625 [TBL] [Abstract][Full Text] [Related]
6. P120ctn may participate in epithelial-mesenchymal transition in OSCC. Zhong C; Zuo Z; Ji Q; Feng D Indian J Cancer; 2016; 53(1):20-4. PubMed ID: 27146732 [TBL] [Abstract][Full Text] [Related]
7. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444 [TBL] [Abstract][Full Text] [Related]
8. CD147 Induces Epithelial-to-Mesenchymal Transition by Disassembling Cellular Apoptosis Susceptibility Protein/E-Cadherin/β-Catenin Complex in Human Endometriosis. Wang C; Zhang J; Fok KL; Tsang LL; Ye M; Liu J; Li F; Zhao AZ; Chan HC; Chen H Am J Pathol; 2018 Jul; 188(7):1597-1607. PubMed ID: 29630856 [TBL] [Abstract][Full Text] [Related]
9. Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition. Zang W; Liu J; Geng F; Liu D; Zhang S; Li Y; Pan Y PeerJ; 2022; 10():e12991. PubMed ID: 35223210 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum. Min J; Mashimo C; Nambu T; Maruyama H; Takigawa H; Okinaga T Arch Oral Biol; 2024 Apr; 160():105897. PubMed ID: 38290225 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway. Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019 [TBL] [Abstract][Full Text] [Related]
13. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma. Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631 [TBL] [Abstract][Full Text] [Related]
17. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma. Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774 [TBL] [Abstract][Full Text] [Related]
18. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling. Yang K; Zhao J; Liu S; Man S Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977 [TBL] [Abstract][Full Text] [Related]
19. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma. Xie Y; Zhong L; Duan D; Li T J Oral Pathol Med; 2019 Nov; 48(10):897-905. PubMed ID: 31318467 [TBL] [Abstract][Full Text] [Related]